Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer

Hamizi S, Freyer G, Bakrin N, Henin E, Mohtaram A, Le Saux O, Falandry C

OncoTargets and Therapy 2013, 6:89-94

Published Date: 14 February 2013